Litcius/Paper detail

Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Claire McGroder, David Zhang, M. Choudhury, Mary Salvatore, Belinda D’Souza, Eric A. Hoffman, Ying Wei, Matthew R. Baldwin, Christine Kim Garcia

2021Thorax224 citationsDOIOpen Access PDF

Abstract

The risk factors for development of fibrotic-like radiographic abnormalities after severe COVID-19 are incompletely described and the extent to which CT findings correlate with symptoms and physical function after hospitalisation remains unclear. At 4 months after hospitalisation, fibrotic-like patterns were more common in those who underwent mechanical ventilation (72%) than in those who did not (20%). We demonstrate that severity of initial illness, duration of mechanical ventilation, lactate dehydrogenase on admission and leucocyte telomere length are independent risk factors for fibrotic-like radiographic abnormalities. These fibrotic-like changes correlate with lung function, cough and measures of frailty, but not with dyspnoea.

Topics & Concepts

MedicineMechanical ventilationTelomerePulmonary fibrosisInternal medicineCoronavirus disease 2019 (COVID-19)FibrosisLactate dehydrogenasePulmonary function testingVentilation (architecture)Lung functionLungPathologyCardiologyDiseaseDNAMechanical engineeringBiologyGeneticsInfectious disease (medical specialty)BiochemistryEngineeringEnzymeChemistryLong-Term Effects of COVID-19COVID-19 and healthcare impactsOccupational and environmental lung diseases
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length | Litcius